Advanced Chronic Kidney Disease Patients Treated With Invasive Heart Procedures Show No Reduction in Rate of Cardiac Events
November 16, 2019
November 16, 2019
NEW YORK, Nov. 16 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
Heart disease is the leading cause of death for the roughly 500 million people worldwide with chronic kidney disease (CKD). Yet such patients have been excluded from most of the major, relevant cardiovascular clinical trials that are meant to guide treatment approaches for them.
Today, an international, federally funded study report . . .
Heart disease is the leading cause of death for the roughly 500 million people worldwide with chronic kidney disease (CKD). Yet such patients have been excluded from most of the major, relevant cardiovascular clinical trials that are meant to guide treatment approaches for them.
Today, an international, federally funded study report . . .